Currently out of the existing stock ratings of Kelly Shi, 45 are a BUY (91.84%), 4 are a HOLD (8.16%).

Kelly Shi

Work Performance Price Targets & Ratings Chart

Analyst Kelly Shi, currently employed at JEFFERIES, carries an average stock price target met ratio of 55.09% that have a potential upside of 26.95% achieved within 159 days.

Kelly Shi’s has documented 98 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on INSM, Insmed at 12-Aug-2025.

Wall Street Analyst Kelly Shi

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 5/13/2025. The price target of $105 was fulfilled within 41 days with a profit of $39.29 (59.79%) receiving and performance score of 14.58.

Average potential price target upside

of $47.44 (34.4%) on ASND (ASCENDIS PHARMA AS).
of $31.5 (37.77%) on INSM (INSMED).
of $14.6 (22.92%) on INCY (YTE).

HGEN Humanigen IMGN ImmunoGen KYMR Kymera Therapeutics MLTX MoonLake Immunotherapeutics IBRX Immunitybio ACET Adicet Bio PTCT PTC Therapeutics ADAG Adagene ASND Ascendis Pharma AS CNTA Centessa Pharmaceuticals PLC ADR FHTX Foghorn Therapeutics INCY yte TIL Instil Bio IMAB I-Mab PROK ProKidney Corp. ALDX Aldeyra The INSM Insmed VSTM Verastem

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tiago Fauth (CREDIT SUISSE)